
Number of publications published per year by Bass, Nathan M.. (Source : PubMed)

Distribution of publications types for Bass, Nathan M.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)



Rifaximin treatment in hepatic encephalopathy.
N. Engl. J. Med.
2010;362;12

Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic.
Hepatology
2010;51;1



Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers.
Radiology
2008;249;1

Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.
J. Hepatol.
2008;49;4

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
Hepatology
2008;48;3


A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
Hepatology
2008;47;6

Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease.
Hepatology
2008;47;4

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging.
Am. J. Transplant.
2007;7;11

Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
Liver Transpl.
2007;13;6

Medical treatment of non-alcoholic steatohepatitis.
Clin Liver Dis
2007;11;1
[ See timeline ] [ See all publications ]
means that Bass, Nathan M. has 33 papers cited a least 33 times - methodology
University of California, San Francisco, San Francisco, California, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.